Advances in Hemophilia A: Strategies for Optimizing Prophylaxis and Joint Health in Adolescents and Adults

This activity is jointly provided/co-sponsored/co-provided by Postgraduate Institute for Medicine and CMEology.

This activity is supported by an independent educational grant from Baxter Healthcare Corporation.

Release date: July 1, 2014

Valid through: July 1, 2015

Target Audience:

This activity has been designed to meet the educational needs of physicians, registered nurses, pharmacists, and medical technologists involved in the care of patients with bleeding disorders.

Program Overview:

Since the introduction of coagulation factor replacement for hemophilia A over 40 years ago, therapeutic advances have dramatically improved patient outcomes and prognosis in this disease. Achieving low annual bleed rates remains a crucial goal for patients and parents of children with hemophilia. However, many clinical challenges remain. Adherence to factor replacement is often suboptimal in patients with hemophilia A, and adolescents transitioning to adult care are especially vulnerable. Effective strategies for maintaining joint health are an important but sometimes underutilized part of ongoing care in patients receiving coagulation factors. This activity will help clinicians enhance their knowledge and competence in the management of patients with hemophilia A. An expert faculty will discuss strategies for improving joint health and enhancing adherence to optimize outcomes of prophylactic factor replacement in adolescents and adults.

Credit Types

2.0 AMA PRA Category 1™ Credit Hours

2.0 Pharmacy Education Contact Hours (0.20 CEUs)

2.0 Nursing Contact Hours

2.0 ASCLS P.A.C.E.® Credit Hours